To evaluate the antidepressant effect of a new treatment principle using low-intensity transcranially applied pulsed electromagnetic fields (T-PEMF) in combination with antidepressants in patients with treatment-resistant depression.
The psychopharmacological treatment (antidepressants, mood stabilizers, antipsychotics, tranquilizers, and hypnotics) was unchanged during the previous four weeks (before treatment) and was maintained on the same dosage throughout the study. In total, 50 patients were included (from June 2006 to February 2009; treatment group n=25, sham exposure group n=25). See here for additional information.
Chistyakov AV et al.
Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression
Dell'Osso B et al.
Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression
Bermpohl F et al.
Effect of low-frequency transcranial magnetic stimulation on an affective go/no-go task in patients with major depression: role of stimulation site and depression severity
Yukimasa T et al.
High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors
Rumi DO et al.
Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study
Shaul U et al.
Modulation of frequency and duration of repetitive magnetic stimulation affects catecholamine levels and tyrosine hydroxylase activity in human neuroblastoma cells: implication for the antidepressant effect of rTMS
Janicak PG et al.
Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial
Nahas Z et al.
Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance